cas 2364560-34-7|| where to buy tert-butyl N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]carbamate

Nom du produit:tert-butyl N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]carbamate

IUPAC Name:tert-butyl N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]carbamate

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:2364560-34-7; Formule moléculaire:C18H23N3O3; Point de fusion:-; Code SMILES:N(C(OC(C)(C)C)=O)[C@H]1C=2C(=CC(=CC2)C=3N=C(CC)ON3)CC1; Densité:

: Numéro de catalogue:CM1046484; Poids moléculaire:329.4; Point d'ébullition:; N° Mdl:; Stockage:

: Oxadiazoles; Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.

: Aficamten; Evaluate Pharma recently issued an article listing "the most valuable potential drugs currently under development", and Aficamten is one of them. Aficamten is a novel cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy, which achieves its therapeutic effect by reducing the hypercontractility of obstructive HCM and improving diastolic function.